Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Tuberculosis

Free Subscription 20.05.2024 3 Clin Infect Dis 2 J Infect 2 J Infect Dis 5 PLoS One 1 Trop Med Int Health

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Clin Infect Dis

1. BURKE RM, Nyirenda SK, Mtenga T, Twabi HH, et al
   Enhanced tuberculosis diagnosis with computer-aided chest X-ray and urine LAM in adults with HIV admitted to hospital (CASTLE study): A cluster randomised trial.
   Clin Infect Dis. 2024 May 15:ciae273. doi: 10.1093.
   PubMed         Abstract available
   
   
2. SHAH NS, Kityo C, Hughes MD, McCarthy C, et al
   Effectiveness of double-dose dolutegravir in people receiving rifampin-based tuberculosis treatment: an observational, cohort study of people with HIV from six countries.
   Clin Infect Dis. 2024 May 13:ciae269. doi: 10.1093.
   PubMed         Abstract available
   
   
3. STEADMAN A, Andama A, Ball A, Mukwatamundu J, et al
   New manual qPCR assay validated on tongue swabs collected and processed in Uganda shows sensitivity that rivals sputum-based molecular TB diagnostics.
   Clin Infect Dis. 2024 Feb 2:ciae041. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   J Infect

4. MUTAVHATSINDI H, Manyelo CM, Snyders CI, Van Rensburg I, et al
   Baseline and end-of-treatment host serum biomarkers predict relapse in adults with pulmonary tuberculosis.
   J Infect. 2024;89:106173.
   PubMed         Abstract available
   
   
5. WAGNEW F, Alene KA, Kelly M, Gray D, et al
   Undernutrition increases the risk of unsuccessful treatment outcomes of patients with tuberculosis in Ethiopia: A multicenter retrospective cohort study.
   J Infect. 2024;89:106175.
   PubMed         Abstract available
   
   

   
   J Infect Dis

6. ESPINOSA-PEREIRO J, Alagna R, Saluzzo F, Gonzalez-Moreno J, et al
   A Systematic Review of Potential Biomarkers for Bacterial Burden and Treatment Efficacy Assessment in Tuberculosis Platform-Based Clinical Trials.
   J Infect Dis. 2024;229:1584-1595.
   PubMed         Abstract available
   
   
7. TAGAMI Y, Horita N, Kaneko M, Muraoka S, et al
   Whole-Genome Sequencing Predicting Phenotypic Antitubercular Drug Resistance: Meta-analysis.
   J Infect Dis. 2024;229:1481-1492.
   PubMed         Abstract available
   
   

   
   PLoS One

8. ARCONADA ALVAREZ SJ, Hoover AT, Greenleaf M, Ray SM, et al
   "An app is just available at all times"-the process and outcomes of converting the Georgia Tuberculosis Reference Guide into a mobile application.
   PLoS One. 2024;19:e0298758.
   PubMed         Abstract available
   
   
9. YENEW B, Kebede A, Alemu A, Diriba G, et al
   Genotypic and phenotypic drug resistance patterns of Mycobacterium tuberculosis isolated from presumptive pulmonary tuberculosis patients in Ethiopia: A multicenter study.
   PLoS One. 2024;19:e0303460.
   PubMed         Abstract available
   
   
10. MOMANYI RK, Kwobah EK, Owiti P, Nyamogoba H, et al
    Psychiatric morbidity among patients on treatment for tuberculosis at a tertiary referral hospital in Western Kenya.
    PLoS One. 2024;19:e0302744.
    PubMed         Abstract available
    
    
11. XU W, Bao X, Lou X, Liu X, et al
    Feature fusion method for pulmonary tuberculosis patient detection based on cough sound.
    PLoS One. 2024;19:e0302651.
    PubMed         Abstract available
    
    
12. OPITO R, Kwenya K, Ssentongo SM, Kizito M, et al
    Treatment success rate and associated factors among drug susceptible tuberculosis individuals in St. Kizito Hospital, Matany, Napak district, Karamoja region. A retrospective study.
    PLoS One. 2024;19:e0300916.
    PubMed         Abstract available
    
    

    
    Trop Med Int Health

13. MOLEMANS M, Kayaert L, Olislagers Q, Abrahams S, et al
    Neighbourhood factors and tuberculosis incidence in Cape Town: A negative binomial regression and spatial analysis.
    Trop Med Int Health. 2024 May 16. doi: 10.1111/tmi.14001.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge.